Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Coverage, context and targeted prevention: optimising our impact.

Aral SO, Cates W Jr.

Sex Transm Infect. 2013 Jun;89(4):336-40. doi: 10.1136/sextrans-2012-050707. Epub 2012 Dec 27.

PMID:
23270932
2.

Tenofovir gel--the new HIV prevention 'banker'?

Bateman C.

S Afr Med J. 2007 Jul;97(7):496, 498. Review. No abstract available.

3.

Antiretrovirals for HIV Exposure Prophylaxis.

Nikolopoulos G, Tsiodras S, Bonovas S, Hatzakis A.

Curr Med Chem. 2012;19(35):5924-39. Review.

PMID:
22963555
4.

Tenofovir: quo vadis anno 2012 (where is it going in the year 2012)?

De Clercq E.

Med Res Rev. 2012 Jul;32(4):765-85. doi: 10.1002/med.21267. Epub 2012 May 11. Review.

PMID:
22581627
5.

Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.

Soriano V, Puoti M, Bonacini M, Brook G, Cargnel A, Rockstroh J, Thio C, Benhamou Y.

AIDS. 2005 Feb 18;19(3):221-40. Review. No abstract available. Erratum in: AIDS. 2005 Mar 24;19(6):3 p following 640.

PMID:
15718833
6.

Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals.

Okwundu CI, Okoromah CA.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007189. doi: 10.1002/14651858.CD007189.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;7:CD007189.

PMID:
19160329
7.

[HIV preexposure prophylaxis].

Olczak A, Grabczewska E.

Przegl Epidemiol. 2012;66(1):79-82. Review. Polish.

8.

The third wave: HIV infection among heterosexuals in the United States and Europe.

Haverkos HW, Quinn TC.

Int J STD AIDS. 1995 Jul-Aug;6(4):227-32. Review. No abstract available.

PMID:
7548282

Supplemental Content

Support Center